Aurobindo Pharma acquires Veritaz


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Drugmaker Aurobindo Pharma will acquire domestic formulation company Veritaz for Rs 171 crore in a cash-free and debt-free way.

Drugmaker Aurobindo Pharma will acquire domestic formulation company Veritaz for Rs 171 crore in a cash-free and debt-free way. The transaction will come into effect on April 1st and will be completed by May 2022. This transaction will also mark the entry of Aurobindo in the domestic market.

Presently, 90% of Aurobindo's sales come from the international market. Veritaz’s acquisition will also help Aurobindo market other biosimilar products. Aurobindo was founded by K. Nityananda Reddy and P. V. Ramprasad Reddy.

Veritaz’s largest brands are Fepanil and Merogram which clocked a revenue of Rs 51 crores in December 2021. The brand has 180 trademarks registered under its name. They mostly cater to anti-infective and pain management therapeutic areas with a presence in over 20 cities and a retailer network of over 50,000. They also plan to enter other categories like cardio-diabetic, orthopaedic and gynaecology. 

Veritaz is Aurobindo’s 7th acquisition. Aurobindo Pharma had first acquired Trident Life Sciences in 2009 for $27.9 million. In 2013, they acquired Hyacinths Pharma and Silicon life Sciences. In 2014, Natrol was acquired for $133 million. Two years later, Generis Farmacêutica was acquired for €135 million. Sandoz International was acquired for $900 million in 2018.

Tags : #AurobindoPharma #Veritaz #acquisition #KNityanandaReddy #PVRamprasadReddy #alert #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026